Suzhou’s BrightGene Bio-Medical Completes $80 Million Pre-IPO Funding

Life Science

Cannabis Trends to Watch in 2019

Cannabis, Life Science

OrigiMed Completes Series B Round Focusing on Creating a Comprehensive Precision Medicine Platform for Oncology

Life Science

Canadian M&A seen rising after hitting 12-year high in 2018

Cannabis, Life Science

Beijing InnoCare Raises $160 Million for Cancer/Autoimmune Drugs

Life Science

Athenex Out-Licenses China Rights to Keratosis/Oncology Drug for $29.5 Million

Life Science

TILT Holdings Agrees to Acquire Jupiter Research

Cannabis, Life Science

StemCyte Receives Phase II Investigational New Drug (IND) Clearance from the U.S. Food and Drug Administration (FDA)

Life Science

China SXT Pharmaceuticals, Inc. Announces First Closing of Initial Public Offering

Life Science

Thousand Oaks Biopharma Closes $45 Million Series A Funding Round

Life Science

Richmond conference to predict best investments for 2019

Cannabis, Life Science

Promega Microsatellite Instability Technology Receives Innovation Designation from Chinese National Medical Products Administration

Life Science

Creso Pharma’s Plans Progress as Israel’s New Medical Cannabis Export Law Passed by Parliament

Cannabis, Life Science

APRINOIA Therapeutics Licenses Tau PET Imaging Tracer APN-1607 to Celgene

Life Science

Antengene Corporation Raises $120 Million in Series B Financing

Life Science